Clinical experience with an injectable hormonal contraceptive depot
DOI:
https://doi.org/10.31403/rpgo.v13i878Abstract
207 highly fertile Peruvian females were studied with a long-acting hormonal contraceptive; this compound was a synthetic gestagen: Norethindrone enanthate; with a dose of 200 mg. every three months there were no pregnancies in a group of 134 patients. In 53 patients receiving the some dose every 4 months occurred 3 pregnancies, demonstrating the reversibility of the contraceptive mechanism. Side effects were observed in the first 3 months with the usual incidence for oral contraceptives, but they diminished to 2.9 % after this period of time. The authors remark the persistence of lactation and disappearance of dysmenorrhea that occurred in most of the patients.Downloads
Download data is not yet available.
Downloads
Published
2015-06-12
How to Cite
Larrañaga Leguía, A., & Kesseru, E. (2015). Clinical experience with an injectable hormonal contraceptive depot. The Peruvian Journal of Gynecology and Obstetrics, 13(1 y 2), 49–58. https://doi.org/10.31403/rpgo.v13i878
Issue
Section
Artículos Originales